NCT00683332View on ClinicalTrials.gov

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

CompletedOBSERVATIONAL
Enrollment

621

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal Infections
Interventions
DRUG

Tigecycline (Tygacil)

This is a non-interventional study; patients are administered Tygacil as prescribed by their doctor as per registered indications stated in product label/insert (50 mg by Intravenous Injection).

Trial Locations (1)

Unknown

Pfizer Investigational Site, Manila

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY